Be empowered with MS views and news. CLICK HERE - - to SUBSCRIBE for The MS BEACON e-Newsletter
MS Views and News uses state-of-the-art technology to provide resources to the MS Community. Visit our MS learning channel on YouTube, to gain knowledge from hundreds of MS educational videos presented by MS Experts from across the USA. Click: www.youtube.com/msviewsandnews
Within this blog you can find MS resources by viewing all showing below pertaining to thousands of MS articles, resources, event timing. Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for those affected by Multiple Sclerosis. * From the comfort of your home, you can join us for our VIRTUAL MS events. To learn more of these virtual events please subscribe here.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Thursday, October 28, 2010
A comprehensive overview of the eight FDA-approved disease-modifying therapies used to slow MS activity (including the newly approved oral therapy, Gilenya), and initial findings on many of the experimental treatments in development for the treatment of MS
Wednesday, October 27, 2010
This is a promotion for the MS Foundation's Cruise for a Cause.
The largest and most revolutionary cruise ship in the world. An architectural marvel at sea, spanning 16 decks. Experience the most innovative and imaginative ship yet, Oasis of the Seas - where, for the first time ever, entertainment areas have become neighborhoods at sea. Find a revolutionary public space combining nature with nautical in the Central Park neighborhood, or old-world charm with a modern twist in the entertaining Boardwalk neighborhood. Visit the Pool and Sports Zone to explore an entire deck of pools and more. And don't forget the Youth Zone - where kids can be kids and parents can be worry-free. With seven distinct onboard neighborhoods, everyone can discover a place for unique experiences.
Some people with MS face unique challenges when traveling. You may feel that you can no longer travel safely or comfortably. But these hurdles can be overcome, and the MSF Cruise for a Cause is a great place to start. On-board, courteous, and attentive staff caters to your needs. Fine food, spectacular entertainment, great shopping, and exciting accessible portside activities are available as well.
Save these dates and join us!
September 10 to 17, 2011Cruise Line: Royal Caribbean
Ship: Oasis of the Seas
Destinations: Bahamas,St Thomas and St. Maarten
Departure: Fort Lauderdale FL 5:00 p.m. September 10, 2011.
Day 2: Nassau, Bahamas 7:00 a.m. -2:00 p.m.
Day 3: Cruising
Day 4: Charlotte Amalie, St. Thomas 9:00 a.m.-.5:00 p.m.
Day 5: Philipsburg St. Maarten 7:00 a.m.-5:00 p.m.
Day 6: Cruising
Day 7: Cruising
Day 8: Arrive Fort Lauderdale.
READ More - including Pricing (per person) and other fees by clicking more
Tuesday, October 26, 2010
By: SHARON WORCESTER, Internal Medicine News Digital Network
Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
TERACLES is the First Phase III Study of an Oral Drug as an Add-On to Standard Therapy in Relapsing Multiple Sclerosis
Monday, October 25, 2010
Help US to Keep YOUR information Up-to-date, so that you do not miss-out on the MS information we provide
We are constantly trying to find ways to improve our services and to stay up-to-date with our members' contact information.
When there is a change in your email address, please contact us by email to update our records.
Write to: email@example.com to update our database.
DATA FURTHER SUPPORTING ANTI-JC VIRUS ANTIBODY ASSAY PRESENTED AT THE 26TH CONGRESS OF THE European Committee for Treatment and Research in Multiple Sclerosis